Position in LLY
as of Jun 30, 2026
· filed Jul 17, 2026
Position Value
$1,101,076
+$253,968 QoQ
Shares Held
918
-0.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.61%
of 13F equity value
Holder Rank
#3,054
of 4,605 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority
Sole 96%
Shared 0%
None 4%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ARVEST INVESTMENTS, INC. holds $10,070,233 across 7 Drug Manufacturers - General names. LLY ranks #4 (10.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
30,803 | $3,958,185 | |
| 2 | JNJ |
Johnson & Johnson
|
7,022 | $1,783,377 | |
| 3 | ABBV |
AbbVie Inc.
|
6,201 | $1,560,419 | |
| 4 | LLY |
ELI LILLY & Co
This page
|
918 | $1,101,076 | |
| 5 | PFE |
Pfizer Inc
|
31,383 | $755,702 | |
| 6 | NVS |
Novartis AG
|
3,314 | $519,370 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
6,805 | $392,104 |
All Filings in LLY
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,101,076 | 918 | Shares | Sole | 2026-07-17 | |
| 2026-03-31 | $847,108 | 921 | Shares | Sole | 2026-04-14 | |
| 2025-12-31 | $1,039,215 | 967 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $2,799,447 | 3,669 | Shares | Sole | 2025-10-14 | |
| 2025-06-30 | $1,001,696 | 1,285 | Shares | Sole | 2025-07-03 | |
| 2025-03-31 | $896,112 | 1,085 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $698,660 | 905 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $770,767 | 870 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $749,654 | 828 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $616,144 | 792 | Shares | Sole | 2024-04-19 | |
| No filing history on record for this holder in this stock. | ||||||